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A central issue in psychiatric genetics is whether positive ﬁndings replicate. Zubenko et al.
(2002b, Mol. Psychiatry 7:460–467) reported an association of the 124-bp allele of D2S2944
with recurrent early-onset major depression for females. We tested for association of this allele
to continuous measures of anxiety, depression and neuroticism in a Dutch sample of 347 males
and 448 females, and to DSM-IV major depression in a subsample of 210 males and 295
females. The association of the 124-bp allele to depression in females was not replicated, but
there were signiﬁcant associations (not signiﬁcant after correction for multiple testing) with
anxiety and anxious depression in males. However, the association occurred in the absence of
evidence for linkage in this region on chromosome 2.
KEY WORDS: Anxiety; association analysis; linkage analysis; major depression; neuroticism; sex-speciﬁc
eﬀects.
Twin and family studies have repeatedly suggested
that genetic factors contribute to the development of
major depressive disorder (MDD) or to quantitative
traits that reﬂect a liability to this disorder, such as
anxiety, depression and neuroticism (Lake et al.,
2000; Sullivan et al., 2000). With the advent of rela-
tively aﬀordable and fast methods for large scale
genotyping, the next aim has become the identiﬁca-
tion of the chromosomal regions or loci involved in
the development of depression via linkage or allelic
association analyses. The results of studies employing
such analyses have implicated diﬀerent loci or
regions, which is not uncommon in psychiatric
genetics. In addition, results found in one sex do not
always replicate in the other.
Sex differences and some ambiguity among re-
sults from association and linkage analyses were
evident in several studies by Zubenko and colleagues.
Zubenko et al. (2002c) used DNA pooling for low
density genome wide association tests of 386 micro-
satellite markers to recurrent/early-onset MDD by
comparing frequencies of multiple alleles between
groups in a case–control design. Their affected sam-
ple consisted of 50 males and 50 females (mean age
32.8, minimum age 18) with ‡2 major depression
episodes, the ﬁrst of which occurred £25 years. The
unaffected sample consisted of an equal number of
males and females partially matched for age (mean
age 37.6, minimum age 18), sex, race and ethnicity
with no individual or family history of mental dis-
orders. For 19 markers across the genome, evidence
of association was obtained in the pooling study.
After genotyping these markers in all individual
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subjects, the allele frequencies in the affected and
unaffected samples were again compared in men and
women separately. Statistically signiﬁcant group dif-
ferences were obtained for all 19 markers, but those
differences were observed for nine markers only in
females and for seven markers only in males. The
124-bp allele of the marker D2S2944 (at 210 cM)
showed the strongest association with recurrent/ear-
ly-onset MDD, but this association was female spe-
ciﬁc (p=0.003).
In a subsequent study, Zubenko et al. (2002b)
presented a more detailed comparison of the frequen-
cies of each allele of D2S2944 in the same sample of
cases and controls. For females, the D2S2944 124-bp
allele was signiﬁcantly more common in cases than
controls (odds ratio 4.5, 95% CI 1.9–10.8). These re-
sults were supported by evidence from a within-family
transmission disequilibrium test of the D2S2944
124-bp allele in another sample of 81 families previ-
ously identiﬁed through individuals with recurrent
early-onset MDD (Zubenko et al., 2001). This ﬁnding
argues against population stratiﬁcation as a trivial
explanation of the association by linkage disequilib-
rium. For the same sample of families, Zubenko et al.
(2003a) presented evidence of cosegregation of MDD
in women with CREB1 (located near D2S2208 at
205 cM). Philibert et al. (2003) replicated the associa-
tion of the 124-bp allele with recurrent early-onset
MDD in a comparatively small sample of females
(78, 11 aﬀected), although they did not employ some
form of transmission disequilibrium testing procedure.
Several studies have used linkage analyses for
RE-MDD or related phenotypes. Table I summarizes
some of the results, emphasizing recurrent early-onset
MDD or MDD and the region containing D2S2944
(Camp and Cannon-Albright, 2005, provide another
summary and discussion of these and other ﬁndings).
Zubenko et al. (2002a) reported results of a linkage
analysis in the region from D2S1384 (200 cM) to
D2S434 (215 cM), which included D2S2944 (210 cM).
Evidence for linkage did not reach signiﬁcance
(p<0.05) for recurrent early-onset MDD in females,
although signiﬁcant linkage was established for less
severe forms of the illness, which were more prevalent
in females. Evidence of linkage was not found for
males.
The linkage study of Zubenko et al. (2003b) was
genome wide. The results in their study were obtained
with a model that included one or both of two co-
variates: sex of aﬀected pairs and a dichotomized
variable which encoded whether or not a family LOD
score at D2S2208 was >0 in Zubenko et al. (2002a).
The latter covariate substantially increased the LOD
score. The eﬀects were again female speciﬁc and oc-
curred for recurrent MDD and less severe disorders,
but not for recurrent early-onset MDD. The linkage
studies of Holmans et al. (2004) and Abkevich et al.
(2003) were genome wide. The results of Holmans
Table I. Summary of Findings of MDD Linkage Studies
Study Sample Phenotypeb Max LODc Chr 2 LODsd
Zubenko et al. (2002a)a 81 Families; 407 ﬁrst,
835 extended relatives
of RE-MDD probands
RE-MDD/F 1.2 0.7
R-MDD/F 1.3 0.9
MMD/F 4 2.4
AMD/F 6.4 4.7
D2S2208/205 cM D2S2944/210 cM
Zubenko et al. (2003b) Same R-MDD/F 8.19 6.72
D2S2321/205 cM D2S2944/210 cM
6.63
D2S427/237 cM
Holmans et al. (2004) 297 Families; 415 indep. ASPs RE-MDD/FM;
MDD/FM
3.73 All LODs <0.55
D15S652/103 cM
Abkevich et al. (2003)a 110 Families; 1890 subjects;
945 (RE)-MDD
(RE)-MDD/M; 6.1 All LODs <1.2
D12S1706/21 cM
aLOD scores read from graph.
bMDD, major depression disorder; RE, recurrent early-onset; R, recurrent; MMD, major mood disorder; AMD, any mood disorder; F,
female; M, male.
cMaximum LOD score in the study and its position.
dLOD scores on chromosome 2 and their positions.
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et al. (2004) were not male speciﬁc, while Abkevich
et al. (2003) reported evidence of linkage for males.
While Zubenko et al. (2002b, c) provided evi-
dence for an association of the 124-bp allele of
D2S2944 to recurrent/early-onset MDD, their link-
age results on chromosome 2 (Zubenko et al., 2002a,
2003b) were obtained for disorders that were either
less severe or more broadly deﬁned than recurrent
early-onset MDD. Furthermore, the best evidence for
linkage was obtained at a location which would re-
quire linkage disequilibrium to extend a considerable
distance from D2S2944. Therefore, the generality of
the association of the 124-bp allele to depression and
related disorders remains to be delineated. We tested
the association of the 124-bp allele of D2S2944 with
quantitative measures of anxiety, depression and
neuroticism assessed by questionnaires in a Dutch
sample of European ancestry [the comorbidity of
DSM-IV MDD and neuroticism has been conﬁrmed
in our sample by Middeldorp et al. (2005)]. Although
those tests are the primary focus, association with a
clinical diagnosis for MDD (DSM-IV), which was
available for a sub sample, was also investigated.
METHOD
Sample and Questionnaires
In 1991, the Netherlands Twin Register (NTR)
started a longitudinal survey study of health and
lifestyle. Questionnaires were sent out in 1991, 1993,
1995, 1997 and 2000 to adolescent and adult twins
and their family members. Twin pairs were asked to
participate in all waves, parents were asked to par-
ticipate in 1991, 1993 and 1995, siblings were in-
cluded since 1995 and spouses in 2000.
Depression was assessed by the anxious depres-
sion symptom scale of the Young Adult Self Report
(YASR) (Achenbach, 1990; Verhulst et al., 1997) and
by the Beck Depression Inventory (BDI) (Beck et al.,
1961). Neuroticism was assessed by the Amsterdamse
Biograﬁsche Vragenlijst (ABV) (Wilde, 1970), whose
neuroticism scale is very similar to that of the
Eysenck Personality Questionnaire (Eysenck et al.,
1985). The Spielberger State Anxiety Inventory
(STAI) (Spielberger et al., 1970) was used to measure
anxiety. The speciﬁc occasions on which those vari-
ables were measured and other details of the study
are provided by Boomsma et al. (2000, 2002).
Based on questionnaire data on anxiety,
depression and neuroticism, a genetic factor score for
each survey was composed which was used for an
extreme discordant and concordant (EDAC) selec-
tion for genome wide marker genotyping for a
quantitative trait locus (QTL) study of anxious
depression (see Boomsma et al., 2000, for a detailed
description). At each occasion from 1991 to 1997,
subjects were classiﬁed as scoring in the upper or
lower tail of the distributions of the genetic factor
scores or as not scoring in one of the tails, the
thresholds being deﬁned by preset cumulative prob-
abilities of the empirical distributions. If at least two
subjects in a family were classiﬁed in one of the tails
at any occasion (thus constituting an extreme con-
cordant or discordant pair) the entire family was se-
lected for genotyping. A total of 2724 participants
were selected. The resulting distributions at each oc-
casion had heavier tails than the original distributions
but also contained a substantial number of subjects
towards the centers of the distributions.
The 2724 participants selected for the QTL study
were asked to provide a buccal swab for DNA iso-
lation. Of the 1962 participants (72%) who returned a
buccal swab, 917 (624 offspring and 293 parents)
were selected for genotyping over the entire genome,
including D2S2944. These subjects, who were of
European ancestry, were mostly selected because they
came from larger participating families. An addi-
tional 337 twins from DZ pairs who had participated
in earlier studies on cardiovascular risk factors
(Boomsma et al., 1993; Snieder et al., 1997) were also
genotyped.
D2S2944 was successfully genotyped in 273
parents (one parent in 51 families, two parents in 111
families) and 876 offspring from 374 families. Since
the subjects in the studies by Zubenko et al. (2002b, c)
were P18 years of age, oﬀspring <18 years of age at
the time of phenotyping were excluded from the
association analyses. The remaining sample consisted
of 273 parents and 795 oﬀspring (347 males and 448
females). The numbers of oﬀspring with a D2S2944
genotype are slightly diﬀerent for each quantitative
phenotype and are presented in Table IV, which
contains results of association analyses.
The 2724 offspring originally selected for geno-
typing were asked if they agreed to being interviewed
on the telephone for administration of the WHO-
CIDI (Wittchen, 1994; World Health Organization,
1992). The interview was standardized through a
computer program (Peters and Andrews, 1995). An
automated scoring procedure was used to obtain
diagnoses for a number of lifetime mental disorders,
which included a lifetime diagnosis of DSM-IV
MDD. Our standardized interview and automated
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scoring procedure do not allow for a reliable estimate
of the number of recurrences, only for whether the
depressive episodes have been single or recurrent. 505
subjects (210 males and 295 females) with a valid
genotype for D2S2944 were successfully interviewed
to obtain a MDD diagnosis.
Genotyping and Error Checking
Genotyping was conducted by the Mammalian
genotyping service (Marshﬁeld Laboratory, USA) for
379 autosomal markers (including D2S2944) from the
10 cM spaced micro satellite screening set 10 (Yuan
et al., 1997). DZ twin pairs from the cardiovascular
studies were genotyped over the entire genome using
a partly overlapping set of markers (including
D2S2944) consisting of a combination of in-house
markers [ALFexpress automated sequencer (Amer-
sham Pharmacia Biotech)] as described by Beekman
et al. (2003), markers from the Weber screening set 8
(ALFexpress) and from the Human Linkage Set V2.5
MD10 en HD5 [ABI Prism DNA Analyzer 3700
(Applied Biosystems)].
Pedigrees were checked for Mendelian errors
with the program Unknown (Schaffer, 1996) and
pedigree relationships in the entire sample with the
GRR program (Abecasis et al., 2001). Mendelian
errors were removed by assigning missing values to
the marker genotypes if the errors appeared inci-
dental. Likelihoods for recombinations were checked
using the program Merlin (Abecasis et al., 2002). One
unlikely recombination was observed at the marker
D2S2944 and the genotype was assigned a missing
value.
IBD Estimation
Marker distances were assigned from the Decode
map (Kong et al., 2002) if available. For markers not
mapped by Decode, the original distance provided on
the Marshﬁeld website (Broman et al., 1998) was
transformed by interpolation from adjacent markers
with known Decode map values. The program Merlin
(Abecasis et al., 2002) was used for a multipoint IBD
estimation using all available markers. For 27 oﬀ-
spring, two of which came from one family, at least
13 markers but not D2S2944 were successfully
genotyped. Oﬀspring for which D2S2944 was not
successfully genotyped can still be useful for IBD
estimation of oﬀspring pairs with a D2S2944 geno-
type. If a minimum of 13 genotyped markers were
available (giving an average spacing of approximately
20 cM) oﬀspring without a D2S2944 genotype were
included in the IBD estimation. These subjects were
used only in the IBD estimation, not in the associa-
tion analyses.
Analyses
The 124-bp allele of D2S2944 was tested for
association with anxiety, depression (YASR and
Beck depression), neuroticism and the DSM-IV
MDD diagnosis. The quantitative scores were trans-
formed by the Van der Waerden transformation
(Lehman, 1975). This transformation makes the
scores more normally distributed. For each variable
two scores were constructed: the average score over
all occasions and the score on the last occasion at
which the subject participated.
A TDT statistics was used to test the association
of D2S2944 with discrete (Abecasis et al., 2000b) and
quantitative phenotypes (Abecasis et al., 2000a). The
latter is a generalization of a model proposed by
Fulker et al. (1999) and produces a TDT for quan-
titative variables. The quantitative model and the
TDT test statistic for discrete variables are imple-
mented in the program QTDT. In the quantitative
model the association eﬀect is partitioned into a be-
tween and within family contribution. For subject j in
family i, gij is deﬁned as the number of 124-bp alleles
minus 1. The between family eﬀect (b) is modeled as
the regression parameter bb associated with bi, the
expected value of gij in family i. If genotypes for both
parents are available, this expectation equals the
average of gij in both parents. If genotypes for both
parents are not available, this expectation is esti-
mated as the average of gij in all the oﬀspring. The
within family contribution (w) is modeled as the
regression parameter bw associated with wij=gij ) bi.
Abecasis et al. (2000a) show that the value of bb
represents two eﬀects: the additive genetic eﬀect of a
locus in linkage disequilibrium with the marker and
eﬀects of stratiﬁcation and admixture, when these
latter eﬀects exist. The value of bw represents the
additive genetic eﬀect only. Families whose oﬀspring
all have gij identical to the expected value bi or its
estimate can contribute only to the estimation of bb
and not to the estimation of bw. For example, families
with two homozygous parents or without genotyped
parents and only one oﬀspring cannot be informative
for association as tested by the null hypothesis bw=0
against the alternative bw „ 0. The within family
eﬀect can be dropped from the model if bb=bw,
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which will usually result in a larger number of sub-
jects that are informative for testing the association.
The phenotypic variance conditional on the
general mean and regressors is modeled as
ra
2+rp
2+re
2, where a refers to the additive effect of a
gene linked to the marker but not necessarily in
linkage disequilibrium, and p and e refer to polygenic
and residual effects. The within family phenotypic
covariances of offspring j and k in family i are
modeled as pijkra
2+drp
2, where pijk is the proportion
of alleles shared identical by descent (IBD) and d is 1
for monozygotic twins and 0.5 for other oﬀspring
pairs. Previous analyses and analyses of the present
data have shown that there is no need to include a
common environment variance component. Since our
sample is not random, d may deviate from 0.5, but we
have generally observed only minor deviations from
0.5 for our genotyped markers, possibly because both
concordant and discordant pairs as well as their family
members were selected for genotyping. Moreover,
simulations conducted by Abecasis et al. (2000a) sug-
gest that the test for a nonzero bw can be robust against
misspeciﬁcation of the covariances.
RESULTS
A comparison of the allele distributions for
parents and offspring from the current study,
including only one MZ twin of a pair, to those pub-
lished in the Zubenko study is presented in Table II.
Our sample contains two alleles, the 100-bp and 132-
bp allele, not present in the Zubenko study. The
frequency of the 124-bp allele in the cases of the
Zubenko study is considerably higher than in our
sample, while the frequency in the controls is lower.
The null hypotheses of independence of sex and
the allele distributions were not rejected for mothers
and fathers and for male and female offspring
(v2=8.56, df=7, p=0.28 for the parents; v2=11.71,
df=8, p=0.16 for the offspring; the largest devia-
tions from independence occurring for rare alleles).
Note, however, that the test for offspring does not
take the dependence due to the family structure into
account. Since the number of possible genotypes is 45
and some of the alleles are rare, a formal test for
Hardy–Weinberg equilibrium was not applied.
Table III contains the distributions of the num-
ber of the 124-bp alleles for parents and oﬀspring.
The null hypotheses of independence of sex and
genotype were not rejected (v2=2.17, df=2, p=0.34
for the parents; v2=4.34, df=2, p=0.11 for the off-
spring). Likewise the null hypothesis of HW-equilib-
rium applied after this dichotomization of the
D2S2944 alleles was not rejected (v2=0.001, df=1,
p=0.97 for the parents; v2=0.88, df=1, p=0.53 for
the offspring).
Table II. Comparison of Allele Distributions for Parents and Oﬀspring from Current Study to Zubenko Study
Frequencies and percentages of alleles for parents and oﬀspring in the current study
Alleles 100 104 108 112 116 120 124 128 132 Row total
Parents
Males 0 1 21 53 61 61 43 17 3 260
0.0 0.4 8.1 20.4 23.5 23.5 16.5 6.5 1.2
Females 0 0 17 52 63 78 61 15 0 286
0.0 0.0 5.9 18.2 22.0 27.3 21.3 5.2 0.0
Allele 0 1 38 105 124 139 104 32 3 546
Total 0.0 0.2 7.0 19.2 22.7 25.5 19.0 5.9 0.5
Oﬀspring
Males 1 0 62 153 189 209 122 53 3 792
0.1 0.0 7.8 19.3 23.9 26.4 15.4 6.7 0.4
Females 1 2 64 169 237 245 180 50 12 960
0.1 0.2 6.7 17.6 24.7 25.5 18.8 5.2 1.3
Allele 2 2 126 322 426 454 302 103 15 1752
Total 0.1 0.1 7.2 18.4 24.3 25.9 17.2 5.9 0.9
Frequencies and percentages of alleles for females cases and controls in the study of Zubenko et al. (2002b)
Cases 0 1 11 14 20 14 32 8 0 100
0.0 1.0 11.0 14.0 20.0 14.0 32.0 8.0 0.0
Controls 0 0 8 16 35 23 11 7 0 100
0.0 0.0 8.0 16.0 35.0 23.0 11.0 7.0 0.0
Allele 0 1 19 30 55 37 43 15 0 200
Total 0.0 1.0 10.0 15.0 28.0 19.0 22.0 8.0 0.0
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Association Analyses
Association analyses were conducted for mean
scores over repeated occasions and for scores ob-
tained on the last survey in which subjects partici-
pated. Since the results were very similar, we focus on
the mean score. The mean ages over occasions for
males and females were 33.3 (s.d. 13.0) and 32.3 (s.d.
12.4), respectively.
The Figures 1 and 2 contain plots of the LOD
scores from a variance components linkage analysis
for chromosome 2 for males and females. The evi-
dence for linkage at the marker was small in both
sexes.
Association with the 124-bp allele was tested for
mean anxiety, depression (YASR and Beck scales),
neuroticism and for MDD. Table IV contains results
for the quantitative variables. Age was included as a
covariate in all models, but its eﬀect was negligible.
The variance ra0
2 of the linked genetic eﬀect(s) was
never statistically signiﬁcant at the 0.05 level. Some
evidence for association is apparent for anxiety and
YASR anxious depression for males (p=0.05 for
YASR on the last occasion), but it occurs in the ab-
sence of evidence for linkage. The justiﬁcation for the
approximate validity of the tests in Table IV is based
on the applicability of asymptotic theory and its
assumptions. QTDT includes permutation tests to
calculate exact p-values under models of fewer
assumptions. The permuted p-values for males were
0.04 for anxiety and 0.08 for YASR anxious depres-
sion (1000 permutations). The Bonferroni adjustment
for males and females separately would require a
0.0125 signiﬁcance level for an overall 0.05 type-I
error rate. Since the variables are correlated, use of
this critical value is rather conservative and therefore
does affect the sensitivity of the tests.
The Marshﬁeld Laboratory determined allele
sizes relative to the sizes of CEPH family 1331.
Table III. Frequencies and Percentages of Number of 124-bp Alleles of Individuals Separately for Male and Female Parents and Oﬀspring
Number of 124-bp alleles
Parents Oﬀspring
0 1 2 0 1 2
Males 91 35 4 287 96 13
0.70 0.27 0.03 0.73 0.24 0.03
Females 88 49 6 317 146 17
0.62 0.34 0.04 0.66 0.30 0.04
Total 179 84 10 604 242 30
0.65 0.31 0.04 0.69 0.28 0.03
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Fig. 1. Male LODs vertical line at D2S2944.
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Fig. 2. Female LODs vertical line at D2S2944.
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Nevertheless, our 124-bp allele may not correspond
to the 124-bp allele assessed in other studies. In that
case, effects may occur for the 120-bp or 128-bp
alleles. However, if some evidence of an association
effect is obtained, the effect of the 124-bp allele in
our sample often is also the strongest effect. The
120-bp or 128-bp alleles do not show comparable
results.
The association can be estimated from a larger
number of subjects if the regression parameters of the
between and within effects are equal, implying no
stratiﬁcation effect. For males, the null hypothesis of
equality was not rejected for any variable, the
smallest p-value being 0.64. For females, p-values for
neuroticism were 0.21. For the other variables the
p-values were ‡0.35. This test can only be rejected
from those observations that are informative under
the full model. Therefore accepting the model under
the null hypothesis as approximately valid perhaps
requires a larger leap of faith than usual. Table IV
nevertheless also contains estimates, subscripted by t,
from the model without within family effect. The
results do not change substantially.
MDD was dichotomized as none versus single or
recurrent and as none versus recurrent. Both twins
from MZ pairs were once included and once excluded
in the analysis, and subjects with no MDD but an-
other diagnosis were once included and once ex-
cluded in the controls. For males and also for the
dichotomization none versus recurrent no sufﬁcient
information remained for a sensible within family
test. For females and males and females combined the
minimum p-values from the permutation tests were
0.54 and 0.25, respectively.
The joint distribution of the zygosity of 124-bp
alleles and MDD is presented in Table V for males
and females. Treating all observations as indepen-
dent, the p-values of the exact test for independence
were 0.37 and 0.20 for males and females. The
p-values were 0.35 and 0.20 after removal of subjects
with no MDD but with another DSM-IV diagnosis.
DISCUSSION
In our sample we found only weak evidence
of association of the D2S2944 124-bp allele with
Table IV. Results of Association of the 124-bp Allele of D2S2944 with Neuroticism, Anxiety, YASR Depression and Beck Depression
Males Females
Neu Anx YASR Beck Neu Anx YASR Beck
r2e0 0.61 0.34 0.43 0.31 0.57 0.49 0.43 0.36
r2p0 0.19 0.56 0.27 0.35 0.57 0.50 0.31 0.52
r2a0 0.19 0.00 0.00 0.00 0.00 0.06 0.23 0.00
r2e 0.63 0.37 0.41 0.32 0.56 0.48 0.42 0.35
r2p 0.16 0.51 0.27 0.34 0.58 0.52 0.3 0.52
r2a 0.19 0.00 0.00 0.00 0.00 0.05 0.22 0.00
bb 0.18 0.16 0.20 0.03 )0.08 )0.01 0.01 )0.04
bw 0.17 0.34 0.27 0.07 0.16 0.17 0.12 0.10
v2 1.0 4.81 3.38 0.22 1.46 1.68 0.83 0.56
Prob 0.32 0.03 0.07 0.64 0.23 0.19 0.36 0.45
I 124 124 115 112 190 191 186 168
r2et 0.63 0.36 0.41 0.31 0.57 0.48 0.42 0.35
r2pt 0.16 0.53 0.27 0.35 0.57 0.53 0.33 0.52
r2at 0.19 0.00 0.00 0.00 0.00 0.05 0.22 0.00
bt 0.18 0.23 0.22 0.04 0.04 0.08 0.06 0.03
v2t 2.85 5.38 6.01 0.21 0.20 0.76 0.47 0.12
Probt 0.09 0.02 0.01 0.65 0.65 0.38 0.49 0.73
N 345 347 319 311 448 448 424 394
r2: variance components.
Subscripts: e, p and a refer to error, polygenic and QTL effects; b and w to between and within family effects; 0 and t to the model without
association effect and to the model without within family effect.
I: number of informative probands for testing the hypothesis bw „ 0; N: total number of probands; v2 : 2 times the log likelihood ratio for
the test bw ¼ 0; Prob: the probability associated with the chi-squared approximation to the test statistic; v2t : )2 times the log likelihood ratio
for the test bw=bb; Probt: the probability associated with the chi-squared approximation to the test statistic.
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anxiety, depression or neuroticism. Our strongest
evidence for association occurs in males for anxiety
and anxious depression. Those effects occur in the
absence of evidence for linkage, although the asso-
ciation cannot be spurious due to stratiﬁcation effects
because the association is partitioned in between and
within family contributions. Zubenko et al. (2002b)
reported association for recurrent early-onset MDD
in females only. Although we did not ﬁnd any asso-
ciation for females, some evidence for linkage in this
region was found for anxious depression as judged by
the estimates of the variances.
Our failure to replicate the speciﬁc association of
the 124-bp allele to female depression is in accor-
dance with the diversity of results from linkage
studies involving MDD and related phenotypes
across different nonrandom samples (e.g. Abkevich
et al., 2003; Holmans et al., 2004; Zubenko et al.,
2003b). Because of variation in populations, the cri-
teria for selection of subjects and choice of pheno-
types evidently can produce diﬀerent results, one
conclusion could be that this region is not involved in
the development of MDD and related quantitative
traits. Alternatively, our study may have lacked
power to detect the association.
Insufﬁcient power may have arisen through a
number of factors, such as too small a sample or too
few extreme subjects. The simulations conducted by
Abecasis et al. (2000a) suggest, that the power for our
numbers of informative females is only 60–80% at
a=0.05 for a marker accounting for 5% of the vari-
ance.
An indication of the frequency of extreme sub-
jects as compared with those in the studies of
Zubenko et al. (2002b, c) can be obtained from our
sub sample of subjects who were interviewed for a
DSM-IV MDD diagnosis. In the studies by Zubenko
et al. (2002b, c), the subjects were probands or
selected through probands. The age at study of the
aﬀected subjects is similar to the age of our aﬀected
subjects, but their controls are approximately eight
years older than our unaﬀected subjects, which may
imply that our presently unaﬀected subjects are at a
higher risk of developing a MDD in the years to
come. Other age characteristics of our aﬀected sub-
jects, such as the age of onset, suggest that our
selection is somewhat broader, but that the extremes
in our selection are probably not too diﬀerent from
those in the studies by Zubenko et al. (2002b, c).
In conclusion, we have failed to detect a robust
association of the 124-bp allele of marker D2S2944
with MDD or anxiety, depression, and neuroticism.
Hence, its reported effects on recurrent early-onset
MDD in females (Zubenko et al., 2002b) do not seem
to generalize to these quantitative risk factors.
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